Back to 
Simplex Trading, LLC
Simplex Trading, LLC
ARQT
Showing 0 of 10 quarters
Position history for Simplex Trading, LLC's holdings in Arcutis Biotherapeutics, Inc.
No. Simplex Trading exited its ARQT (Arcutis Biotherapeutics) position in Q2 2024. Its Q1 2024 13F listed 25,795 shares worth $255,000. Simplex Trading first reported ARQT in Q1 2021 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.